Skip to main content
BRAIN Biotech AG logo

BRAIN Biotech AG — Investor Relations & Filings

Ticker · BNN ISIN · DE0005203947 LEI · 391200JKPVHLD6JLZ107 F Professional, scientific and technical activities
Open in API
Filings indexed 370 across all filing types
Latest filing 2026-05-28 Earnings Release
Country DE Germany
Listing F BNN

About BRAIN Biotech AG

https://www.brain-biotech.com/

BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.

Recent filings

Filing Released Lang Actions
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
Earnings Release Classification · 89% confidence The document is a corporate press release announcing BRAIN Biotech AG’s half-year (6M) results, summarizing key financial figures and segment performance, and confirming guidance. It provides selected financial data and narrative but is not the full interim report itself. This matches an Earnings Release (initial announcement of periodical financial results). H1 2026
2026-05-28 English
Half-yearly financial report 2025/2026
Interim / Quarterly Report Classification · 95% confidence The document is titled “2025/26 HALF-YEAR REPORT as of 31 March 2026” and contains a complete set of interim financial statements (consolidated income statement, balance sheet, cash flow statement, notes) along with an Interim Group Management Report. It is a comprehensive half-year financial report, matching the definition of an Interim/Quarterly Report. H1 2026
2026-05-28 English
Report Publication Announcement 2026
Report Publication Announcement Classification · 95% confidence The document is a preliminary announcement stating the date and links for the upcoming half‐year (Q2) financial report publication under the German Securities Act. It contains no financial data itself but merely notifies investors of the report’s disclosure date and where to access it. Under the “menu vs meal” rule, this qualifies as a Report Publication Announcement, not the report itself.
2026-05-20 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2025 bis zum 31.03.2026
Report Publication Announcement Classification · 97% confidence The document is a brief notice informing stakeholders that the half-year financial report (covering 01.10.2025 to 31.03.2026) is available online and specifying publication dates and platforms. It does not contain the actual report’s financial data but merely announces its availability. This fits the criteria for a Report Publication Announcement (RPA).
2026-05-20 German
Hinweis auf Halbjahresfinanzbericht vom 01.10.2025 bis zum 31.03.2026
Report Publication Announcement Classification · 95% confidence The document is a brief notice indicating that the half-year financial report for the period 01.10.2025–31.03.2026 is available online via a provided URL. It does not contain the actual financial statements or substantive data but merely announces the publication and availability of the report. Under the “menu vs meal” rule, this is a report publication announcement, not the report itself.
2026-05-20 German
BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Regulatory Filings Classification · 90% confidence The document is a corporate press release (Regulatory News) announcing that BRAIN Biotech has been granted a key patent. It contains no financial results, dividend, management changes, M&A activity, or other specific events covered by the defined categories. It is not the text of a report itself, nor a notice of report publication. Therefore it falls into the fallback Regulatory Filings category (RNS).
2026-03-23 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.